Matthew J Wieduwilt

6PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAdolescent healthRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 30, 2025
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.

Matthew J Wieduwilt, Jun Yin, Oudom Kour

|Feb 14, 2022
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.

Anjali S Advani, Anna Moseley, Kristen M O'Dwyer

|Jun 22, 2021
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.

Pinkal M Desai, Janice Brown, Saar Gill

|Jun 05, 2021
Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR.

Matthew J Wieduwilt, Wendy Stock, Anjali Advani

|Mar 31, 2021
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR.

Matthew J Wieduwilt, Wendy Stock, Anjali Advani

|Apr 07, 2017
Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients.

Brice Jabo, John W Morgan, Maria Elena Martinez

Pageof 1

Frequent Collaborators

4 joint publications

Mark R Litzow

3 joint publications

Anjali S Advani

3 joint publications

Wendy Stock

2 joint publications

Selina Luger